H. Res. 1109 is a House of Representatives resolution that expresses support for National Women and Girls HIV/AIDS Awareness Day and catalogues federal and global HIV statistics and disparities affecting women and girls.
The resolution highlights CDC and UNAIDS data, emphasizes the disproportionate burden on women of color, and reiterates CDC testing and prenatal screening recommendations.
Beyond recognition, the resolution urges sustained investments in prevention, care, and research; encourages youth‑friendly and culturally responsive services including access to PrEP, PEP, and antiretroviral therapy; and calls for U.S. engagement in foreign assistance and diplomatic efforts to address violence, discrimination, and gaps in sexual and reproductive health access that drive infections among women and girls.
At a Glance
What It Does
The resolution officially supports the goals of the March 10 awareness day and lists factual findings from CDC and UNAIDS before advancing nine non‑binding policy statements urging increased focus on prevention, testing, treatment access, and international assistance. It does not create new law or appropriate funds; rather it directs attention and expresses congressional priorities.
Who It Affects
The resolution is targeted at federal health and foreign‑assistance policymakers, public health agencies, advocacy groups, health care providers, and institutions that set sexual health education standards. It speaks to stakeholders involved in HIV prevention, maternal health, and global HIV programming.
Why It Matters
Resolutions shape congressional priorities and can be used by agencies and advocates to justify program expansion, funding requests, or diplomatic emphasis. For compliance officers and program managers, the text signals where Congress intends attention—testing, PrEP/ART access, maternal screening, and culturally competent services—without changing statutory requirements.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
H. Res. 1109 is a non‑binding House resolution that does two things: it records a set of factual findings about HIV/AIDS domestically and globally, and it articulates nine policy stances that the House 'supports' or 'encourages.' The findings assemble CDC and UNAIDS statistics (total people living with HIV in the U.S., the share who are women, new infection counts, and global burden) and call out demographic disparities, notably higher rates among African American and Latina women.
The policy stances in the resolve clauses are declarative rather than prescriptive: they reaffirm support for investment in prevention, treatment, and research; they press for culturally responsive, youth‑friendly health services; they highlight prenatal screening and the role of comprehensive care in preventing perinatal transmission; and they urge inclusion of up‑to‑date HIV prevention information (including PrEP/PEP) in sexual education curricula. The resolution also explicitly connects U.S. diplomatic and foreign assistance tools to objectives such as combating gender‑based violence and discrimination that drive HIV infections among women and girls.Because the document is a House resolution, it does not change federal health regulations or appropriations.
Its practical effect is political and programmatic: it provides an evidentiary and rhetorical basis for agencies, grantmakers, and advocates to prioritize the named activities and populations. For implementers, the text signals congressional interest in expanding routine testing, improving PrEP and ART access, and pushing culturally competent programming domestically and in U.S. foreign assistance portfolios.Notably, the resolution ties clinical guidance (CDC testing and prenatal screening recommendations) to broader social drivers of the epidemic—gender norms, violence, and limited sexual and reproductive health access—thereby framing HIV prevention as both a biomedical and a socio‑structural challenge.
It also emphasizes girls and young women in high‑incidence settings, pointing U.S. global health engagement toward multi‑sectoral interventions rather than purely clinical responses.
The Five Things You Need to Know
H. Res. 1109 is a non‑binding House resolution that expresses support for National Women and Girls HIV/AIDS Awareness Day and makes findings drawn from CDC and UNAIDS data.
The resolution cites U.S. figures including about 1.2 million people living with HIV (≈22% women), roughly 31,800 new annual infections, and CDC guidance recommending at‑least‑one HIV test for ages 13–64 and routine screening for pregnant people.
It calls out racial and ethnic disparities explicitly, noting African American women represent roughly 50% of new HIV diagnoses among U.S. women and Latina women roughly 20%.
The text urges expanded access to prevention and treatment tools—PrEP, PEP, antiretroviral therapy—and promotes youth‑friendly, culturally responsive services and inclusive sexual education curricula.
While advocating stronger U.S. investment in global efforts, the resolution specifically links foreign assistance to addressing gender‑based violence, discrimination based on sexual orientation and gender identity, and adolescent girls’ limited access to sexual and reproductive health services.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Epidemiological and equity findings
The preamble collects domestic CDC statistics and international UNAIDS estimates to establish a factual baseline: prevalence, annual new infections and deaths, and the gendered share of the epidemic. It also isolates disparities—specifically higher burden among African American and Latina women—and lists behavioral and structural drivers (gender norms, violence, transactional sex). For analysts, this is the evidentiary foundation the resolve clauses lean on to justify policy emphasis.
Formal support for Awareness Day
This short clause formally states congressional support for National Women and Girls HIV/AIDS Awareness Day. Its main practical role is symbolic: it authorizes members and stakeholders to cite House support when organizing outreach, awareness events, or grant proposals, but it carries no regulatory or funding effect.
Domestic commitments: recognition, investment, and care
These clauses recognize historical progress, recommit to ending the epidemic, call for stronger sustained investment in prevention, care and research, and emphasize reducing disparities and improving access to life‑saving medications. They also flag prenatal screening and comprehensive care to prevent perinatal transmission. Practically, agencies and grantees can use this language to justify prioritizing programs that expand testing, PrEP/ART access, and targeted outreach to disproportionately affected communities.
Global policy and foreign assistance priorities
The resolution endorses U.S. investment in multi‑sectoral global efforts to reduce infections among women and girls and calls for diplomatic and assistance activities that address violence, discrimination, and lack of SRH access. While non‑binding, these clauses signal congressional expectations for the State Department, USAID, and global health implementers to integrate gender‑based violence prevention and rights‑based sexual and reproductive health into HIV programming.
Service delivery and education priorities
These clauses encourage youth‑friendly, culturally responsive health services and explicit inclusion of current, medically accurate HIV prevention information (PrEP/PEP) in sexual education. The language points to program design elements—accessibility, cultural appropriateness, voluntary routine testing, and linkages to care—that funders and service providers may be expected to adopt or emphasize in future solicitations and guidance documents.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Women and girls, particularly women of color: The resolution directs attention and congressional rhetoric toward the disproportionate burden borne by Black and Latina women, giving advocates a legislative text to support targeted prevention and care programs.
- Pregnant people and infants: By endorsing prenatal screening and comprehensive perinatal care, the resolution reinforces strategies that reduce vertical transmission and can be cited to expand maternal HIV services.
- Community‑based organizations and advocates: The findings and policy stances provide a congressional endorsement that advocacy groups can use to press for funding, programmatic prioritization, and culturally competent service design.
- Public health researchers and program implementers: The resolution’s emphasis on evidence‑based, multi‑sectoral approaches and research helps justify proposals and program evaluations that focus on gendered drivers of HIV.
Who Bears the Cost
- Federal health agencies (HHS, CDC) and foreign assistance agencies (State/USAID): Although the resolution does not appropriate funds, it increases congressional expectations for programming and reporting, which may translate into pressure for new budgets or reprogramming.
- Health care providers and health systems: Calls for routine testing, youth‑friendly services, and expanded access to PrEP/ART imply implementation costs—training, staffing, outreach, and billing changes—especially for community clinics serving marginalized populations.
- School districts and education authorities: The push for inclusive, medically accurate sexual education may require curriculum revisions, staff training, and policy changes; in politically contested jurisdictions this can generate implementation friction.
- Insurers and payers: Increased emphasis on access to PrEP and ART creates policy pressure to ensure coverage and reduce cost barriers, which can have downstream cost implications for public and private payers.
Key Issues
The Core Tension
The central tension is between a strong, gender‑focused public health push—calling for expanded testing, biomedical prevention, and social‑structural programming—and the reality that this resolution does not allocate funds or change law; it raises expectations without prescribing how to reconcile contested policy areas (sex education, SRH rights) with limited budgets and fragmented governance, forcing implementers to choose where to pursue change first.
H. Res. 1109 is aspirational: it lists priorities and encourages actions but does not create legal obligations, appropriate money, or set timelines.
That means the resolution’s impact depends on whether agencies, appropriators, and foreign assistance planners translate rhetorical support into funded programs, regulatory changes, or grant guidance. For program managers, the resolution is a lever for advocacy but not a roadmap—there are no metrics, deadlines, or designated funding streams attached.
The resolution also bundles biomedical interventions (testing, PrEP/ART, prenatal screening) with social and structural remedies (addressing gender‑based violence, discrimination, and SRH access). Operationalizing that blend is hard: measuring program impact across sectors requires coordinated indicators, cross‑agency collaboration, and funding models that many existing programs lack.
Finally, several of the resolution’s recommendations—comprehensive, inclusive sexual education and rights‑based SRH services—are politically contested at state and local levels, so federal endorsement may provoke resistance or uneven implementation across jurisdictions.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.